The introduction of direct-acting antivirals (DAAs) in late 2013 changed the treatment landscape for hepatitis C virus (HCV) infection, heralding a new era with a profound upgrade in therapeutic efficacy, tolerability, and convenience. This eCourse details current guidance for management of patients with HCV infection in the primary care setting, including screening for and diagnosis of HCV, individualization of therapy, recognition and management of side effects, when to refer a patient to specialist care, and strategies for counseling patients about current treatments and liver wellness.
Audio-enhanced slide lecture
To promote the identification and treatment of patients with HCV infection through the implementation of current recommendations for screening and diagnosis, and the individualization of therapy selection and monitoring strategies based on current evidence and clinical practice guidelines.
After completing this activity, participants should be better able to:
- Institute guideline-recommended screening for HCV infection
- Identify treatment options for management of various HCV genotypes
- Recommend HCV therapeutic protocols based on individual patient factors, including prior treatment history and complicating comorbidities
- Educate patients on current strategies for the treatment of HCV infection, including the need for adherence and long-term monitoring for HCV-related complications
Nurse practitioners and physician assistants
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nursing contact hours: 1.00, which includes 0.25 hours of pharmacology credit
CNE course advisor: Mary Knudtson, DNSc, NP, University of California, Santa Cruz
This program has been reviewed and is approved for a maximum of 1.00 of AAPA Category 1 CME credits by the AAPA Review Panel. Approval is valid for one year from the issue date of April 20, 2017. Participants may submit the post-test at any time during that period.
This program was planned in accordance with AAPA CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
This activity is supported by an educational grant from AbbVie Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, the AAPA, or AbbVie Inc.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are expected to disclose to the audience any significant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Fox has nothing to disclose with regard to commercial interests.
Mr Davis has nothing to disclose with regard to commercial interests.
The Planning Committee for this activity included Ruth Cohen and Devera Pine of Continuing Education Alliance; Mary Knudtson, DNSc, NP, of the University of California, Santa Cruz; and Mark Christiansen, PhD, PA-C, of the University of the Pacific. The members of the Planning Committee have no significant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Listen to the presentation and study the program slides
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: April 20, 2017
Expiration date: April 20, 2018
© 2018 Practicing Clinicians Exchange. All Rights Reserved. APCE91816